1998
Pretreatment plasma HVA predicts neuroleptic response in manic psychosis
Mazure C, Bowers M. Pretreatment plasma HVA predicts neuroleptic response in manic psychosis. Journal Of Affective Disorders 1998, 48: 83-86. PMID: 9495606, DOI: 10.1016/s0165-0327(97)00159-6.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAntipsychotic AgentsBipolar DisorderFemaleHaloperidolHomovanillic AcidHumansMaleMethoxyhydroxyphenylglycolMiddle AgedPerphenazinePrognosis
1997
Recent life stressors and biological markers in newly admitted psychotic patients
Mazure C, Quinlan D, Bowers M. Recent life stressors and biological markers in newly admitted psychotic patients. Biological Psychiatry 1997, 41: 865-870. PMID: 9099413, DOI: 10.1016/s0006-3223(96)00222-3.Peer-Reviewed Original Research
1994
Elevated plasma monoamine metabolites in eating disorders
Bowers M, Mazure C, Greenfeld D. Elevated plasma monoamine metabolites in eating disorders. Psychiatry Research 1994, 52: 11-15. PMID: 8047617, DOI: 10.1016/0165-1781(94)90115-5.Peer-Reviewed Original ResearchAdolescentAdultAnalysis of VarianceFeeding and Eating DisordersFemaleHomovanillic AcidHumansMethoxyhydroxyphenylglycol
1992
Lithium in combination with perphenazine: effect on plasma monoamine metabolites
Bowers M, Mazure C, Nelson J, Jatlow P. Lithium in combination with perphenazine: effect on plasma monoamine metabolites. Biological Psychiatry 1992, 32: 1102-1107. PMID: 1477190, DOI: 10.1016/0006-3223(92)90190-b.Peer-Reviewed Original Research
1991
Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis
Mazure C, Nelson J, Jatlow P, Bowers M. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis. Biological Psychiatry 1991, 30: 475-482. PMID: 1932395, DOI: 10.1016/0006-3223(91)90309-a.Peer-Reviewed Original ResearchMeSH KeywordsAcute DiseaseAdolescentAdultBipolar DisorderChromatography, High Pressure LiquidDepressive DisorderDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHomovanillic AcidHumansMaleMethoxyhydroxyphenylglycolMiddle AgedPerphenazinePrognosisProspective StudiesPsychiatric Status Rating ScalesPsychotic DisordersSchizophreniaSchizophrenic PsychologyConceptsPlasma homovanillic acidHomovanillic acidFree homovanillic acidClinical responseEarly clinical responsePlasma-free homovanillic acidUseful clinical predictorClinical predictorsNeuroleptic treatmentAcute psychosisDopamine metabolismNoradrenergic functioningMethoxyhydroxyphenylglycolFavorable responsePsychotic inpatientsGood responseSignificant decline
1990
Psychotogenic Drug Use and Neuroleptic Response
Bowers MB, Mazure CM, Nelson JC, Jatlow PI. Psychotogenic Drug Use and Neuroleptic Response. Schizophrenia Bulletin 1990, 16: 81-85. PMID: 1970670, DOI: 10.1093/schbul/16.1.81.Peer-Reviewed Original ResearchConceptsDrug useNeuroleptic responseDual diagnosis patientsDoses of haloperidolPsychotic malesDevelopment of psychosisPsychotogenic drugsDiagnosis patientsDopaminergic mechanismsPrior historyPsychotic disordersMeans of effectsRefractorinessSeparate studiesMalesEarly stagesHaloperidolPatientsIllnessPsychosisDoses
1987
Plasma catecholamine metabolites in subtypes of major depression
Mazure C, Bowers M, Hoffman F, Miller K, Nelson J. Plasma catecholamine metabolites in subtypes of major depression. Biological Psychiatry 1987, 22: 1469-1472. PMID: 3676373, DOI: 10.1016/0006-3223(87)90105-3.Peer-Reviewed Original Research